Maxim Group Upgrades CNS Pharmasceuticals Inc. (CNSP) to Buy, 'Berubicin Glioblastoma Data is Coming into View'

Go back to Maxim Group Upgrades CNS Pharmasceuticals Inc. (CNSP) to Buy, 'Berubicin Glioblastoma Data is Coming into View'
(NASDAQ: CNSP) Delayed: 5.52 +0.37 (7.18%)
Previous Close $5.15    52 Week High
Open $5.50    52 Week Low
Day High $5.70    P/E N/A 
Day Low $5.39    EPS
Volume 6,685